Professor Beverley Vollenhoven, Department of Obstetrics and Gynaecology, Monash University

Associate Professor Vollenhoven is a Reproductive Endocrinologist and Infertility specialist. She is Head of Gynaecology at Monash Health, Deputy Head of Obstetrics and Gynaecology in the Department of Obstetrics and Gynaecology Monash University and a clinician at Monash IVF. At Monash Health she is the Head of the Contraceptive Counselling Clinic, a Reproductive Endocrinologist at the Menopause Clinic and the Long Term Follow Up Clinic Of Children with Cancer.

She has a sub-specialty qualification in Reproductive Endocrinology and Infertility (CREI) with her areas of clinical interest being infertility, polycystic ovarian syndrome, eating disorders, paediatric and adolescent gynaecology and menopause. She also has a clinical and research interest in the cause and treatment of uterine fibroids (leiomyomas).

Associate Professor Vollenhoven’s other research interests are infertility, particularly IVF, ovulation and ovulation disorders such as PCOS, Turner’s Syndrome and menopause.

She has more than 100 publications in both journals and books. She is the Head of the Contraceptive Counselling Clinic at Monash Health and has an appointment as a Reproductive Endocrinologist at the Menopause Clinics at the Monash Medical Centre. She has previously been a Chairperson of the Victorian Regional Committee of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists and is a member of the Examinations Committee.

She is currently an examiner for both the specialist and sub specialist exams.  She is a senior examiner for the Australian Medical Council.  She is on the Advisory Committee for Prescription Medicines (a subcommittee of the Therapeutic Goods Administration) and is a member of 11 national and international societies.


Selected publications

  • Pritchard N, Healey M, Sorby KL, Sivapalan S, Osianlis T, Jatkar S, Robinson K, Sultana F, Burmeister L, Kaul V, Vollenhoven BJ (2015) A case control study of melatonin with or without coenzyme Q10 in improving oocyte quality and outcomes in in vitro fertilization, Reproductive Biology Insights, vol 8, issue 1, pp. 1-7.

  • Heng S, Dynon K, Li Y, Edgell TA, Walton K, Rombauts L, Vollenhoven BJ, Nie G (2015) Development of a high-throughput assay for human proprotein convertase 5/6 for detecting uterine receptivity, Analytical Biochemistry [P], vol 475,pp. 14-21.

  • Vollenhoven BJ, Lethaby A (2015) Fibroids (uterine myomatosis, leiomyomas)., Clinical evidence [P], vol 06, pp. 814-829.

  • Motteram C, Vollenhoven BJ, Hope N, Osianlis T, Rombauts L (2015) Live birth rates after combined adjuvant therapy in IVF-ICSI cycles: a matched case-control study, Reproductive Biomedicine Online [P], vol 30, issue 4, pp. 340-348.

  • Rodda CP, Benson JE, Vincent AJ, Whitehead CL, Polyakov A, Vollenhoven BJ (2015) Maternal vitamin D supplementation during pregnancy prevents vitamin D deficiency in the newborn: an open-label randomized controlled trial., Clinical Endocrinology [P], vol 83, pp. 363-368.

  • Heng S, Paule SG, Li Y, Rombauts L, Vollenhoven BJ, Salamonsen LA, Nie G (2015) Posttranslational removal of alpha-dystroglycan N terminus by PC5/6 cleavage is important for uterine preparation for embryo implantation in women, Faseb Journal [P], vol 29, issue 9, pp. 4011-4022.

  • Smith V, Osianlis T, Vollenhoven BJ (2015) Prevention of Ovarian Hyperstimulation Syndrome: A Review., Obstetrics and Gynecology International [E], vol 514159, pp. 1-10.

  • Paule SG, Nebl T, Webb A, Vollenhoven BJ, Rombauts L, Nie G (2015) Proprotein convertase 5/6 cleaves platelet-derived growth factor A in the human endometrium in preparation for embryo implantation, Molecular Human Reproduction [P], vol 21, issue 3, pp. 262-270.

  • Swanson AE, Griffin K, Brent R, Vollenhoven BJ (2015) Vaginal burn from alkaline Bbttery in an 8-year-old, Journal of Pediatric and Adolescent Gynecology [P], vol 28, issue 4, pp. e99-e100.

  • Fernando SV, Osianlis T, Vollenhoven BJ, Wallace EM, Rombauts L (2014) A pilot double-blind randomised placebo-controlled dose-response trial assessing the effects of melatonin on infertility treatment (MIART): study protocol., BMJ Open [E], vol 4, issue 8, pp. e005986-e005994.